CannaPharmaRX, Inc.
CPMD - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.42M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.42 Million |
|---|---|
| Enterprise Value | $22.09 Million |
| Earnings per Share | $-0.02 |
| Beta | 0.47 |
| Outstanding Shares | 682,482,306 |
Return
| Return on Equity | 36.71% |
|---|---|
| Return on Assets | -164.22% |
| Return on Invested Capital | 30.47% |
Valuation & Multiples
| P/E Ratio | -0.12 |
|---|---|
| PEG | -0.33 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 13 |
| Enterprise Value to EBIT | -2.82 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.94 |
| Debt to Equity | -0.67 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About CannaPharmaRX, Inc.
26 employees
CEO: Constantine Nkafu
CannaPharmaRX, Inc. is a Canadian enterprise actively involved in the cannabis sector. The company focuses on identifying, acquiring, and developing diverse projects for cultivating cannabis. Founded in 1998, its main offices are located in Calgary, Canada.